Filter
502
Text search:
management
of
seizures
Featured
87
106
Language
Document type
289
113
46
27
11
8
5
1
1
1
Countries
39
19
19
12
11
10
7
7
7
6
6
6
5
5
5
5
5
4
4
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
146
83
44
23
20
16
3
Toolboxes
114
28
27
21
20
18
16
14
11
8
7
7
6
6
5
5
5
5
3
3
2
1
Bull World Health Organ 2016;94:554–556 | doi: http://dx.doi.org/10.2471/BLT.15.162610
Ces questions fréquemment posées (FAQs) ont été élaborées par le Groupe de travail sur les maladies infectieuses du Groupe l'alimentation central sur des nourrissons en situation d'urgence (IFE) en se basant sur les recommandations les plus récentes, les connaissances collectives et les donn
...
WHO GUIDELINES REVIEW COMMITTEE
Accessed: 10.03.2019
mhGAP Training Manual for the mhGAP Intervention Guide for mental, neurological and substance use disorders in non-specialized health settings – version 2.0 (for field testing)
Paediatrics
Chapter I.2
Introduction
Chapter A.13
SCOPING QUESTION: For adults and children with medication-resistant convulsive epilepsy, which anti-epileptic medications produce benefits and/or harm in the specified outcomes when compared to a placebo or a comparator?
Developmental disorders
Chapter C.2
2014 Edition
Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4).
Patel V, Chisholm D, Dua T, et al., editors.
Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2016 Mar 14.
7 February 2019
The Guide
An update from the EU Early Warning System
Mood disorders
Chapter E.2
